Aprea Therapeutics, Inc. (NASDAQ:APRE) Sees Large Growth in Short Interest

Published on January 1, 2025

with the SEC. 34.19% of the stock is owned by institutional investors. About Aprea Therapeutics ( Get Free Report ) Aprea Therapeutics,